Defining high, medium and low impact prognostic factors for developing multiple sclerosis

作者: Mar Tintore , Àlex Rovira , Jordi Río , Susana Otero-Romero , Georgina Arrambide

DOI: 10.1093/BRAIN/AWV105

关键词:

摘要: Natural history studies have identified factors that predict evolution to multiple sclerosis or risk of disability accumulation over time. Although these are based on large multicentre cohorts with long follow-ups, they limitations such as lack standardized protocols, a retrospective data collection systematic magnetic resonance imaging acquisition and analysis protocol, often resulting in failure take oligoclonal bands into account joint covariates the prediction models. To overcome some limitations, aim our study was identify stratify baseline demographic, clinical, radiological biological characteristics might development using multivariate approach prospective cohort patients clinically isolated syndromes. From 1995 2013, 1058 syndromes were included. We evaluated influence prognostic for developing definite sclerosis, McDonald (Expanded Disability Status Scale score 3.0) univariate (hazard ratio 95% confidence intervals) (adjusted hazard Cox regression ultimately included 1015 followed mean 81 (standard deviation = 57) months. Female/male 2.1. Females exhibited similar conversion compared males. Each younger decade at onset associated greater protective effect disability. Patients optic neuritis had lower [hazard 0.6 (0.5-0.8)] progression 0.5 (0.3-0.8)]; however, this remained marginal only [adjusted (0.4-1.0)] adjusted The presence increased 1.3 (1.0-1.8)] 2.0 (1.2-3.6)] independently other factors. 10 more brain lesions 11.3 (6.7-19.3)] 2.9 (1.4-6.0)]. Disease-modifying treatment before second attack reduced (0.4-0.9)] (0.3-0.9)]. conclude demographic topographic low-impact factors, is medium-impact factor, number high-impact factor.

参考文章(37)
Johann Sellner, Jörg Kraus, Amer Awad, Ron Milo, Bernhard Hemmer, Olaf Stüve, The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors Autoimmunity Reviews. ,vol. 10, pp. 495- 502 ,(2011) , 10.1016/J.AUTREV.2011.02.006
B. G. WEINSHENKER, B. BASS, G. P. A. RICE, J. NOSEWORTHY, W. CARRIERE, J. BASKERVILLE, G. C. EBERS, The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. ,vol. 112, pp. 133- 146 ,(1989) , 10.1093/BRAIN/112.1.133
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, R. Pelayo, M. Comabella, J. Sastre-Garriga, X. Montalban, Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology. ,vol. 67, pp. 968- 972 ,(2006) , 10.1212/01.WNL.0000237354.10144.EC
M. Koch, E. Kingwell, P. Rieckmann, H. Tremlett, , The natural history of secondary progressive multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 81, pp. 1039- 1043 ,(2010) , 10.1136/JNNP.2010.208173
Nils Koch-Henriksen, Per Soelberg Sørensen, The Changing Demographic Pattern of Multiple Sclerosis Epidemiology Lancet Neurology. ,vol. 9, pp. 520- 532 ,(2010) , 10.1016/S1474-4422(10)70064-8
Mar Tintoré, Alex Rovira, Jordi Rio, Carlos Nos, Elisensa Grivé, Neus Téllez, Raul Pelayo, Manuel Comabella, Xavier Montalban, Is optic neuritis more benign than other first attacks in multiple sclerosis Annals of Neurology. ,vol. 57, pp. 210- 215 ,(2005) , 10.1002/ANA.20363
Christel Renoux, Sandra Vukusic, Yann Mikaeloff, Gilles Edan, Michel Clanet, Bénédicte Dubois, Marc Debouverie, Bruno Brochet, Christine Lebrun-Frenay, Jean Pelletier, Thibault Moreau, Catherine Lubetzki, Patrick Vermersch, Etienne Roullet, Laurent Magy, Marc Tardieu, Samy Suissa, Christian Confavreux, Natural History of Multiple Sclerosis with Childhood Onset The New England Journal of Medicine. ,vol. 110, pp. 897- 904 ,(2007) , 10.1056/NEJMOA067597
C. Polman, L. Kappos, M. S. Freedman, G. Edan, H.-P. Hartung, D. H. Miller, X. Montalbán, F. Barkhof, K. Selmaj, B. M. J. Uitdehaag, S. Dahms, L. Bauer, C. Pohl*, R. Sandbrink*, , Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b Journal of Neurology. ,vol. 255, pp. 480- 487 ,(2008) , 10.1007/S00415-007-0733-2
Ruth Dobson, Sreeram Ramagopalan, Gavin Giovannoni, The effect of gender in clinically isolated syndrome (CIS): a meta-analysis Multiple Sclerosis Journal. ,vol. 18, pp. 600- 604 ,(2012) , 10.1177/1352458511426740